Pain<unk>  is used primarily to treat both acute and chronic severe pain. Its duration of analgesia is about three to seven hours. Side-effects of nausea and constipation are rarely severe enough to warrant stopping treatment. It is used for pain due to myocardial infarction and for labor pains. However, concerns exist that<unk>  may increase<unk> rtality in the event of non ST elevation myocardial infarction.<unk>  has also traditionally been used in the treatment of acute pulmonary edema. A 2006 review, though, found little evidence to support this practice. A 2016 Cochrane review concluded that<unk>  is effective in relieving cancer pain. Shortness of breath<unk>  is beneficial in reducing the symptom of shortness of breath due to both cancer and noncancer causes. In the setting of breathlessness at rest or on minimal exertion from conditions such as advanced cancer or end-stage cardiorespiratory diseases, regular, low-dose sustained-release<unk>  significantly reduces breathlessness safely, with its benefits maintained over time. Opioid use disorder<unk>  is also available as a slow-release formulation for opiate substitution therapy (OST) in Austria, Germany, Bulgaria, Slovenia, and Canada for persons with opioid addiction who cannot tolerate either methadone or buprenorphine. File:GT-Capros-Morphinsulfat-2018.Two capsules (5 mg & 10 mg) of<unk>  sulfate extended- release File:Morphine 1mL Vial.1 milliliter ampoule containing 10 mg of<unk>
Morphine
Codeine
Nalorphine
Methadone
Isomethadone
Normethadone
Butorphanol
Fentanyl